Bibliography
- FARVOLDEN P, KENNEDY SH, LAM RW: Recent developments in the psychobiology and pharmacotherapy of depression: optimizing existing treatments and novel approaches for the future. Expert Opin. Investig. Drugs (2003) 12(1):65-86.
- HOLTZHEIMER PE, NEMEROFF CB: Emerging treatments for depression. Expert Opin. Pharmacother. (2006) 7(17):2323-2339.
- GREENBERG PE, BIRNBAUM HG: The economic burden of depression in the US: societal and patient perspectives. Expert Opin. Pharmacother. (2005) 6(3):369-376.
- SHELTON RC: Antidepressant therapy: new targets for drug development. Expert Opin. Ther. Patents (2001) 11(11):1693-1711.
- MACE S, TAYLOR D: Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression. Expert Opin. Pharmacother. (2000) 1(5):917-933.
- VALUCK RJ, LIBBY AM, SILLS MR, GIESE AA, ALLEN RR: Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study. CNS Drugs (2004) 18(15):1119-1132.
- FERGUSON D, DOUCETTE S, GLASS KC et al.: Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomized controlled trials. Br. Med. J. (2005) 330(7488):396-399.
- RYAN ND: Treatment of depression in children and adolescents. Lancet. (2005) 366(9489):933-940.
- WOHLFARTH TD, VAN ZWIETEN BJ, LEKKERKERKER FJ et al.: Antidepressants use in children and adolescents and the risk of suicide. Eur. Neuropsychopharmacol. (2006) 16(2):79-83.
Patents
- HOFFMAN-LA ROCHE: WO04080460 (2004).
- SCHERING: WO01007050 (2001).
- SCHERING: US6262066 (2001).
- SCHERING: WO0006545 (2000).